Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

NCT ID: NCT02096783

Last Updated: 2019-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized pilot clinical trial studies the feasibility of a pre-operative and/or post-operative scripted sexual health informational intervention and how well it works in improving sexual function in patients with gynecologic cancer. Discussing sexual outcomes and counseling options with patients may help improve sexual outcomes and/or anxiety after primary gynecologic cancer treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To evaluate the feasibility of patient recruitment, including time required to consent, enroll and retain the necessary number of participants.

II. To determine the distribution of candidate primary patient-reported outcome measures, including time to resumption of sexual activity, global satisfaction with sex life, sexual function and anxiety in this particular population.

III. To establish the prevalence of patient recall of the intervention to determine the most effective time at which to deliver the intervention.

OUTLINE: Patients are randomized to 1 of 4 treatment arms.

ARM I: Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.

ARM II: Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.

ARM III: Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.

ARM IV: Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Disorder Cervical Cancer Endometrial Cancer Female Reproductive Cancer Gestational Trophoblastic Tumor Ovarian Epithelial Cancer Ovarian Germ Cell Tumor Sexual Dysfunction Uterine Sarcoma Vaginal Cancer Vulvar Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (standard counseling)

Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.

Group Type ACTIVE_COMPARATOR

counseling intervention

Intervention Type OTHER

Given standard counseling

questionnaire administration

Intervention Type OTHER

Ancillary studies

Arm II (standard counseling, scripted intervention)

Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.

Group Type EXPERIMENTAL

informational intervention

Intervention Type OTHER

Given scripted intervention

counseling intervention

Intervention Type OTHER

Given standard counseling

questionnaire administration

Intervention Type OTHER

Ancillary studies

Arm III (standard counseling, scripted intervention)

Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.

Group Type EXPERIMENTAL

informational intervention

Intervention Type OTHER

Given scripted intervention

counseling intervention

Intervention Type OTHER

Given standard counseling

questionnaire administration

Intervention Type OTHER

Ancillary studies

Arm IV (standard counseling, scripted intervention)

Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.

Group Type EXPERIMENTAL

informational intervention

Intervention Type OTHER

Given scripted intervention

counseling intervention

Intervention Type OTHER

Given standard counseling

questionnaire administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

informational intervention

Given scripted intervention

Intervention Type OTHER

counseling intervention

Given standard counseling

Intervention Type OTHER

questionnaire administration

Ancillary studies

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

counseling and communications studies

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a new suspected or confirmed gynecologic malignancies
* Patients plan to have primary surgery at either the University of Chicago Hospital or the University of Wisconsin Hospital
* Patients must be English speaking

Exclusion Criteria

* Previous treatment of any cancer excluding skin cancer
* Patients with a suspected benign gynecologic process
* Patients who are prisoners or incarcerated
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Kushner

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin, Madison

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

https://cancer.wisc.edu/

University of Wisconsin Carbone Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2014-00471

Identifier Type: REGISTRY

Identifier Source: secondary_id

UW13080

Identifier Type: OTHER

Identifier Source: secondary_id

P30CA014520

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2014-0122

Identifier Type: OTHER

Identifier Source: secondary_id

A532820

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/OBSTET & GYNECOL/OBSTET

Identifier Type: OTHER

Identifier Source: secondary_id

UW13080

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Women's Health Communication Study
NCT05359952 COMPLETED NA